论文部分内容阅读
目的:探讨BiPAP无创通气在治疗高龄急性左心衰竭中的应用效果。方法:对62例急性左心衰竭的高龄患者分为干预组和对照组,两组均给予吸氧、强心、利尿、扩血管等常规治疗,但干预组联合应用BiPAP无创通气治疗。分别测定治疗前及治疗后1h动脉血SaO2、PaO2、PaCO2,观察HR、RR、MAP及临床疗效,并进行比较。结果:干预组治疗后HR、MAP、RR、SaO2、PaO2各指标较治疗前及对照组明显改善(P<0.01);两组治疗后PaCO2均下降,但比较差异无统计学意义(P>0.05)。干预组插管率、住院天数较对照组显著减少,总体临床有效率明显增高(P<0.05)。结论:早期使用BiPAP无创通气辅助治疗,对抢救高龄急性左心衰竭患者有一定的临床价值。
Objective: To investigate the application of BiPAP noninvasive ventilation in the treatment of elderly patients with acute left heart failure. Methods: A total of 62 elderly patients with acute left heart failure were divided into intervention group and control group. Both groups were given conventional therapy such as oxygen inhalation, cardiac, diuretic and vasodilator. However, non-invasive ventilation with BiPAP was used in the intervention group. The levels of SaO2, PaO2 and PaCO2 in arterial blood before treatment and 1h after treatment were measured respectively. HR, RR, MAP and clinical efficacy were observed and compared. Results: The indexes of HR, MAP, RR, SaO2 and PaO2 in the intervention group were significantly improved after treatment (P <0.01), while the PaCO2 in both groups decreased after treatment, but the difference was not statistically significant (P> 0.05 ). The intubation rate and hospital stay in the intervention group were significantly decreased compared with the control group, and the overall clinical effective rate was significantly increased (P <0.05). Conclusion: The early use of noninvasive ventilation BiPAP adjuvant therapy for the treatment of elderly patients with acute left heart failure have some clinical value.